ENDRA Life Sciences extends collaborative research agreement with GE through Dec 2024

ENDRA Life Sciences Inc.

Amendment 5 extends the term of the GE collaboration to December 16, 2024.
Original agreement dated April 22, 2016; this is the fifth amendment.
No financial terms disclosed; the amendment is filed as Exhibit 10.1.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

ENDRA Life Sciences Inc. amended Collaborative Research Agreement with General Electric Company valued at Extended term to December 16, 2024 (effective 2022-12-16).

Action: amendment
Agreement: collaboration
Counterparty: General Electric Company
Value: Extended term to December 16, 2024
Effective: 2022-12-16

Exact text from the filing

On December 16, 2022, ENDRA Life Sciences Inc. (the “Company”) entered into Amendment 5 (the “Amendment”) to that certain Collaborative Research Agreement between the Company and General Electric Company (“GE”), dated as of April 22, 2016, as amended (the “Agreement”). The Amendment extends the term of the Agreement to December 16, 2024.

View on SEC.gov

38 material agreements filed in the last 30 days. Browse all material agreements →

ENDRA Life Sciences Inc. filing history →

Source: SEC EDGAR

accession 0001654954-22-016650

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.